The respiratory symptoms produced by COVID-19 are more severe in patients with previous CVD, which has been related to higher secretion of angiotensin converting enzyme 2 (ACE2) in such patients compared to healthy subjects [3]. This evidence concerns the gene ACE2 and COVID-19.